Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies
if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the
same subfield and year (this is the minimum needed to enter the top 1%, not the average
within it), or reaches the top citation threshold in at least one of its specific research
topics.
Phase III Multicenter Randomized Trial of Oxaliplatin Added to Chronomodulated Fluorouracil–Leucovorin as First-Line Treatment of Metastatic Colorectal Cancer
20001.1k citationsB Perpoint, Rachid Zidani et al.profile →
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late)
cites ·
hero ref
This map shows the geographic impact of B Perpoint's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by B Perpoint with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites B Perpoint more than expected).
This network shows the impact of papers produced by B Perpoint. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by B Perpoint. The network helps show where B Perpoint may publish in the future.
Co-authorship network of co-authors of B Perpoint
This figure shows the co-authorship network connecting the top 25 collaborators of B Perpoint.
A scholar is included among the top collaborators of B Perpoint based on the total number of
citations received by their joint publications. Widths of edges
represent the number of papers authors have co-authored together.
Node borders
signify the number of papers an author published with B Perpoint. B Perpoint is excluded from
the visualization to improve readability, since they are connected to all nodes in the network.
Mosnier, Jean‐François, et al.. (1996). An immunohistochemical study of the simultaneous expression of bcl-2 and p53 oncoproteins in epithelial tumors of the colon and rectum.. PubMed. 120(7). 654–9.25 indexed citations
Mismetti, Patrick, B Perpoint, S Laporte‐Simitsidis, et al.. (1992). [Chronopharmacology of fractionated heparin (nadroparin) administrated by subcutaneous route at prophylactic doses in healthy volunteers].. PubMed. 47(6). 557–60.4 indexed citations
Decousus, Hervé, B Perpoint, Patrick Mismetti, Michel Ollagnier, & Patrice Queneau. (1990). Good clinical practices in phase I studies. Fundamental and Clinical Pharmacology. 4(S2). 163s–165s.1 indexed citations
Queneau, Patrice, et al.. (1985). [Self-medication in rheumatologic consultation. Apropos of a study on 895 patients].. PubMed. 52(2). 79–84.5 indexed citations
16.
Decousus, H, Marine L. Croze, J. Jaubert, et al.. (1985). [Nycthemeral change in the anticoagulant effect of heparin given at a constant rate by the intravenous route].. PubMed. 300(9). 385–8.1 indexed citations
Gabbai, Alberto Alain, et al.. (1982). [Acro-osteolysis in leprosy. Apropos of 19 personal cases].. PubMed. 49(2). 111–9.5 indexed citations
19.
Perrin‐Fayolle, M, Arjan Bel, R Harf, et al.. (1980). [Asthma and gastro-esophageal reflux. Results of a survey over 150 cases (author's transl)].. PubMed. 36(4). 225–30.25 indexed citations
20.
Perrin‐Fayolle, M, G Braillon, R Lombard-Platet, et al.. (1980). [Asthma and gastro-esophagal reflux (GER). Results of surgical treatment of reflux in 50 patients (author's transl)].. PubMed. 36(4). 231–7.5 indexed citations
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.